Vaaman Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -23.83%
- Profit Growth -27.35%
- Ebitda -124.38%
- Net Worth 40.26%
- Total Assets 69.69%
About Vaaman Laboratories
Vaaman Laboratories Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2017 (Seven years and two months 10 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishna Jami and Sridevi Rachuri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TG2017PTC121211
- Company No.
121211
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vaaman Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakrishna Jami  | Director | 14-Dec-2017 | Current |
| Sridevi Rachuri | Director | 14-Dec-2017 | Current |
Financial Performance of Vaaman Laboratories.
Vaaman Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.83% decrease. The company also saw a substantial fall in profitability, with a 27.35% decrease in profit. The company's net worth Soared by an impressive increase of 40.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaaman Laboratories?
In 2023, Vaaman Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vyas Bio Life Sciences Private LimitedRamakrishna Jami is a mutual person
- Hanker Systems (India) Private Limited
Sridevi Rachuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaaman Laboratories?
Unlock and access historical data on people associated with Vaaman Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaaman Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaaman Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.